Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01)

2003153 citationsJournal Article

Authors

Stéphane Culine · Art Research Centre of the Slovak Academy of Sciences

Alain Lortholary · Art Research Centre of the Slovak Academy of Sciences

Jean‐Jacques Voigt · Art Research Centre of the Slovak Academy of Sciences

R. Bugat · Art Research Centre of the Slovak Academy of Sciences

Christine Théodore · Art Research Centre of the Slovak Academy of Sciences

Frank Priou · Art Research Centre of the Slovak Academy of Sciences

Abstract

This study demonstrates the activity of both the GC and IC regimens. There was toxicity associated with both regimens. Additional studies of combination chemotherapy regimens are required.

Topics & Keywords

Cancer Diagnosis and Treatment Tumors and Oncological Cases Oral and Maxillofacial Pathology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 21, Issue 18, pp. 3479-3482

DOI: 10.1200/jco.2003.12.104

Field-Weighted Citation Impact: 2.82